GDF15 and neoplasm: In light of this, our in vitro results with cell lines, PDXO and in vivo results with PDX-derived tumor tissues offer a more nuanced picture: GDF15 is a pharmacodynamic response biomarker of eribulin, even while it is also associated with the transitory DTP state between drug sensitivity and full resistance.